MASH Clinical Research Study
STUDY LOCATION: Carmel, NY
Looking for Adults with MASH to Participate in a Research Study
The ENLIGHTEN Fibrosis research study is testing an investigational study drug for adults with metabolic dysfunction-associated steatohepatitis (MASH).
To be eligible, you must:
- 18 to 75 years old,
- Diagnosed with MASH and liver scarring (fibrosis),
There are other requirements that the study team will discuss with you.
What to expect:
- Possible access to the investigational study drug— 2 in 3 participants will receive active study drug; 1 in 3 participants will receive placebo, which has no active ingredients,
- Study support and monitoring by a healthcare team.
All will be provided at no cost.